Skip to main content

Tag: Europe

The Future Of Cannabis And Digital Innovation

As the cannabis industry continues to grow and evolve, digital technology is poised to play an increasingly important role. From seed-to-sale tracking to customer relationship management, cannabis businesses are turning to software-as-a-service (SaaS) solutions, mobile apps, web 2.0, and big data analytics to improve efficiency, compliance, and customer experience. In the panel discussion in the video embedded below from the recent International Cannabis Business Conference in Berlin, tech specialists explore the latest trends and opportunities in cannabis technology and discuss how digital tools can help businesses stay ahead in a rapidly changing industry. Panelists include:

    • Christopher Budd – Co-Founder & Subject Matter Expert, Isolocity
    • Nohtal Partansky – Co-Founder & CEO, Sorting Robotics
    • Lewis Koski – Chief Strategy Officer, METRC
    • Hans Harders – Regional Director, CCELL
    • Jürgen Bickel – Managing Director, Storz & Bickel

We look forward to seeing you in Berlin in 2024, as well as at our upcoming science and technology event in Slovenia this September!

One Global Cannabis Industry: Who Will Be The Winners And Losers?

The global cannabis industry is still emerging. The commodity cannabis is becoming more and more relevant for conventional industries, from food and health care via fashion to luxury niche segments. With adult-use reform coming across several nations, the opportunity for other industries in those countries has been unlocked. The biggest question today is: where are global cannabis sectors going and where will the best investments be? Panelists recently discussed this at the International Cannabis Business Conference’s Global Investment Forum in Berlin, as seen in the embedded video below. Panelists include:

  • David Traylor – Senior Managing Director, Golden Eagle Partners
  • Oliver Lamb – Co-Founder and Investment Manager, Óskare Capital
  • Trenton Birch – Co-Founder and CEO, Cheeba Africa
  • Bret Worley – CEO and President, MC Global Holdings

This panel also includes a guest appearance by legendary entertainer Jim Belushi. We look forward to seeing you in Berlin in 2024, as well as at our upcoming science and technology event in Slovenia this September!

Policymaker Points To Schengen Agreement As Major Hurdle For European Cannabis Reform

In the mid-1980s a big effort was waged in Europe to promote ‘free movement’ to help the continent’s working population by increasing the places where people could feasibly carve out a viable living. Free movement involves lowering controls at borders for residents of participating jurisdictions.

The concept of free movement reached a big milestone in 1985 with the initial signing of the Schengen Agreement (named after a small village in Luxembourg). Belgium, Germany, France, Luxembourg, and the Netherlands were the original signers, agreeing to gradually remove controls at their internal borders and to ‘introduce freedom of movement for all nationals of the signatory countries.’

The implementation of the Schengen Agreement officially began in 1995 and initially involved just seven EU countries. However, it has since expanded to most EU countries, with the exception of Bulgaria, Cyprus, Ireland, and Romania. By many measures, the free movement effort has yielded several positives for the European continent.

Unfortunately, it may also be a major hurdle for cannabis policy modernization efforts on the continent according to Mikuláš Peksa, Chairperson of the European Pirate Party.

“Any country wishing to legalise cannabis faces obstacles making legislation compliant with international agreements.” Mikuláš Peksa stated according to original reporting by Business of Cannabis.

“However, this is achievable particularly for countries outside the European Union, but the biggest obstacle for countries in the EU is the Schengen Agreement.” Peksa went on to state. He also indicated that an amendment to the Schengen  Agreement may be on the way. “Our aim is to make legalisation possible for all member states.”

Whether an amendment makes it to the finish line or not in the near future is anyone’s guess, but one thing is for sure – the longer lawmakers drag their feet at the continental level, the farther removed from reality continental and international agreements will become.

The legal cannabis industry is on the move at the national level in many parts of Europe, in addition to the long-established unregulated market that is found throughout the continent. To refrain from modernizing continental and international agreements in order to permit countries to modernize their own domestic cannabis policies is to deny reality. Nations like Germany will have their efforts slowed down by the European Union to some degree, but certainly not halted.

Cannabis commerce and use are not going anywhere. The status quo is a complete waste of limited public resources by every measure and it’s beyond time for a new approach. There is no valid reason why countries in Europe, and the rest of the world, shouldn’t be able to set their own policies for domestic cannabis activity. If a country wants to cling to prohibition, as ridiculous as that approach would be, then so be it.

The seemingly never-ending wrangling between national lawmakers in Europe and the European Union is both frustrating and exhausting. Fortunately, the coalition of pro-modernization lawmakers in Europe is increasing in size, and the same is true beyond the continent’s borders where the Schengen Agreement and other European provisions do not apply.

The European Union has to be feeling the squeeze whether they want to admit it or not, and at some point, it will presumably yield movement, both in regards to the Schengen Agreement and to all other provisions that are currently holding cannabis policy modernization efforts back.

 

Overcoming International Cannabis Logistical Challenges

The emerging international cannabis industry is currently governed by a complex web of laws, rules, and regulations that are constantly shifting and evolving. With more countries reforming their cannabis policies and regulations, the regulatory layers will continue to increase in volume for the foreseeable future.

Yoram Eshel, CEO of Cannabilog, recently presented tips and insight regarding how to navigate the ‘regulatory maze’ in an effective way as part of his presentation at the recent International Cannabis Business Conference in Berlin. Eshel analyzes current international supply chain trends, provides an update on regulatory requirements in various markets, and discusses what to anticipate soon. He also discusses the ‘do’s and don’ts’ when shipping cannabis products worldwide.

We look forward to seeing you in Berlin in 2024, as well as at our upcoming science and technology event in Slovenia this September!

Advancing The Cannabinoid Scientific Landscape

The field of cannabinoid research is advancing, with new discoveries being made about the potential therapeutic benefits of these compounds. However, for these discoveries to be translated into effective treatments for patients, it is essential that proper due diligence is done, and well-designed clinical trials programs are initiated.

In this presentation from the recent International Cannabis Business Conference in Berlin, Terry O’Regan, President of Brains Bioceutical, discusses the course, challenges, considerations, and rewards for advancing the cannabinoid scientific research landscape.

We look forward to seeing you in Berlin in 2024, as well as at our upcoming science and technology event in Slovenia this September!

Opening Your Mind to the Future of Cannabis

To truly understand the future of cannabis, it’s important to approach it from different angles and challenge existing perceptions and stigmas. This presentation from the recent International Cannabis Business Conference’s Global Investment Forum in Berlin by international cannabis expert Lisa Haag (founder of MJ_Universe) offers a fresh perspective on the cannabis industry, exploring its potential from a variety of viewpoints and shedding light on untapped opportunities. By breaking down barriers and opening our minds to new ideas, we can pave the way for a more innovative, inclusive, and successful cannabis industry.

We look forward to seeing you in Berlin in 2024, as well as at our upcoming science and technology event in Slovenia this September!

Mastering The Challenge Of European Cannabis Market Saturation And Oversupply

Different nations across Europe allow for the cultivation, manufacturing, and processing of medical cannabis. Few of the facilities are truly EU-GMP compliant and able to deliver what was promised. Europe’s markets are competing and not collaborating. Few real sales markets other than Germany are established. Some countries like the Czech Republic, France, or Poland show tendencies with a rising number of prescriptions and new regulations for patient access. The German market itself is oversaturated and has many regulatory hurdles to consider. All in all, investors should understand the complexity of market dynamics, especially in regard to timeline and planning of such complex ventures. Below is an embedded video of a panel discussion about this topic that was recently held at the International Cannabis Business Conference’s Global Investment Forum in Berlin. Panelists include:

  • Lisa Haag – Founder, MJ_Universe (moderator)
  • David Engel – CEO/President, Full Moon Real Estate Investments And Ondara Directorship SLU
  • Dr. rer. nat. Adrian Fischer – Co-Founder and Managing Director, DEMECAN
  • Vera Broder – CEO, MHI Cultivo Medicinal SA.
  • Alexander Rieg – Founder, AR Pharma Consulting

We look forward to seeing you in Berlin in 2024, as well as at our upcoming science and technology event in Slovenia this September!

What Is The Outlook For Core Cannabis Market Developments In Europe?

The European Union is a trade union with no borders. Nevertheless, cannabis regulation is a very domestic topic and markets still face different rules and regulations depending on their national regulatory framework.

What will the situation look like from a mid-term perspective? How many member states will have regulations for adult use cannabis? How far will the harmonization of joint market organization develop? Below is an embedded video of an insightful panel discussion that took place at the recent International Cannabis Business Conference’s Global Investment Forum in Berlin two weeks ago touching on those topics and many more. Panelists include:

We look forward to seeing you in Berlin in 2024, as well as at our upcoming science and technology event in Slovenia this September!

What Is Next For The Cannabis Industry?

The emerging legal cannabis industry is continuing to undergo a dramatic evolution, particularly in Europe. The momentum for global reform is greater now than at any other time since the dawn of prohibition, and the biggest domino to date is teetering and getting closer to toppling with every passing day. That domino is, of course, Germany.

Cannabis advocates have fought for reform in Germany for many years, however, the legalization effort picked up considerable steam in mid-2021 when the results of the federal election that year yielded a governing coalition that quickly expressed its desire to modernize Europe’s cannabis policies.

Germany was already home to the largest legal medical cannabis industry in Europe at the time, and initially, it seemed that Germany would launch legal national adult-use cannabis sales in a quick fashion. Then, for over a year, German Health Minister Karl Lauterbach worked behind the scenes, with details of his legalization plan leaking every once in a while.

Eventually, Minister Lauterbach held a press conference in October 2022 to announce some of the provisions he would be seeking but made it abundantly clear that his next stop was the European Union to try to get its permission to proceed.

Unfortunately, the effort hit some turbulence once Germany’s Health Minister started negotiating with the European Union, with Minister Lauterbach providing an update in April 2023 in which he indicated that the European Union would allow parts of the previously outlined legalization plan to proceed and prohibit other parts.

The main component that the European Union stated it would not permit was nationwide adult-use cannabis sales to anyone of legal age. The blocking of that robust provision seemed to send many newer industry members into a bit of a spiral. The fact of the matter is that cannabis reform rarely, if ever, follows a linear path. It is full of twists and turns, and Germany is the latest example of that.

With those twists and turns comes opportunity, as not everyone is able to navigate the shifting landscape. People who are able to navigate the shifting landscape, that can identify trends, and maximize windows of opportunity, will reap significant rewards.

What legalization will ultimately look like in Germany once it is finally implemented is something that we will have to wait and see, however, the basic provisions are already known – personal cultivation, possession, and consumption will be legal and noncommercial clubs will be permitted.

Eventually, regional adult-use commerce pilot programs will launch as well. All of that creates opportunities for entrepreneurs, investors, and industry service providers if they know what to anticipate and where to focus on developing innovative ideas.

The best way to learn what is next for the emerging cannabis industry, both in Germany and beyond, is to hear from true international cannabis experts that spend every day on the frontlines of cannabis reform and industry. Fortunately, the upcoming International Cannabis Business Conference in Berlin, Germany later this month provides that exact opportunity.

Following yet another successful cannabis super-event in Barcelona, the International Cannabis Business Conference is once again bringing its flagship B2B event and tradeshow back to Berlin, Germany on June 29th-30th, 2023. In addition to the B2B event, which is the largest of its type in Europe, the International Cannabis Business Conference will also hold a Global Investment Forum in Berlin on June 27th.

Both events will feature leading cannabis industry experts, and the B2B event has a panel specifically dedicated to discussing what is next for the international cannabis industry now that the curtain dropped in Germany. The panel will feature:

Over 5,000 cannabis leaders from over 80 countries will be represented at the International Cannabis Business Conference in Berlin and that includes representatives from every sector of the industry as well as leading international cannabis policymakers and industry service providers.

Attend the International Cannabis Business Conference in Berlin to network with investors, entrepreneurs, industry regulators, and international policymakers and take your industry pursuits to the next level. Secure your tickets now before the event sells out!